Literature DB >> 10383831

Scoring of skin rejection in a swine composite tissue allograft model.

M Zdichavsky1, J W Jones, E T Ustuner, X Ren, J Edelstein, C Maldonado, W Breidenbach, S A Gruber, M Ray, J H Barker.   

Abstract

BACKGROUND: For the first time, we define and correlate visual and histologic grading systems of composite tissue allograft (CTA) skin rejection in a large-animal model and determine the utility of these grading systems for early diagnosis and monitoring of rejection.
MATERIALS AND METHODS: Sixteen pairs of outbred swine underwent transplant of a forelimb osteomyocutaneous free flap. Group I (n = 6) did not receive immunosuppressive therapy. Group II (n = 10) received oral cyclosporin A, mycophenolate mofetil, and prednisone. The flap was visually inspected and protocol skin biopsies were taken at frequent intervals over a 90-day period. Visual Grades 0 (no rejection) to 4 (severe rejection) were assigned based on skin color, bleeding from biopsy site, and blister formation. Histologic Grades 0 to 4 were assigned based on the degree of vasculitis, folliculitis, dermal inflammation, and epidermal degeneration present.
RESULTS: All Group I animals progressively rejected their graft by Day 7. Group II grafts survived from 19 and 90 days; 93% of 115 biopsy specimens were read to be within +/-1 histologic score of their assigned flap visual grade. Visual assessment carried an 8% false positive and 39% false negative rate with regard to biopsy-proven rejection. However, 81% of missed rejection specimens were histologic Grade 1. Biopsy, when visually indicated, would detect all rejection episodes when histologically Grade 1 or 2 and still potentially reversible.
CONCLUSIONS: Visual scoring of CTA skin serves as a useful tool for initially detecting rejection, but repeated histologic evaluation is necessary for monitoring the subsequent course of the graft. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383831     DOI: 10.1006/jsre.1999.5673

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Bone flap perfusion assessment using near-infrared fluorescence imaging.

Authors:  John T Nguyen; Yoshitomo Ashitate; Ian A Buchanan; Ahmed M S Ibrahim; Sylvain Gioux; Priti P Patel; John V Frangioni; Bernard T Lee
Journal:  J Surg Res       Date:  2012-05-24       Impact factor: 2.192

2.  Short-term outcome after transvaginal mesh repair of pelvic organ prolapse.

Authors:  Daniel Altman; Tapio Väyrynen; Marie Ellström Engh; Susanne Axelsen; Christian Falconer
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06

3.  Imaging human skin autograft integration with optical coherence tomography.

Authors:  Anthony J Deegan; Jie Lu; Rajendra Sharma; Samuel P Mandell; Ruikang K Wang
Journal:  Quant Imaging Med Surg       Date:  2021-02

4.  Preconditioned hyperbaric oxygenation protects skin flap grafts in rats against ischemia/reperfusion injury.

Authors:  Nan Kang; Yong Hai; Fang Liang; Chun-Jin Gao; Xue-Hua Liu
Journal:  Mol Med Rep       Date:  2014-03-24       Impact factor: 2.952

5.  A structurally distinct TGF-β mimic from an intestinal helminth parasite potently induces regulatory T cells.

Authors:  Chris J C Johnston; Danielle J Smyth; Ravindra B Kodali; Madeleine P J White; Yvonne Harcus; Kara J Filbey; James P Hewitson; Cynthia S Hinck; Alasdair Ivens; Andrea M Kemter; Anna O Kildemoes; Thierry Le Bihan; Dinesh C Soares; Stephen M Anderton; Thomas Brenn; Stephen J Wigmore; Hannah V Woodcock; Rachel C Chambers; Andrew P Hinck; Henry J McSorley; Rick M Maizels
Journal:  Nat Commun       Date:  2017-11-23       Impact factor: 14.919

Review 6.  Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches.

Authors:  Rita Diehl; Fabienne Ferrara; Claudia Müller; Antje Y Dreyer; Damian D McLeod; Stephan Fricke; Johannes Boltze
Journal:  Cell Mol Immunol       Date:  2016-10-10       Impact factor: 11.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.